GeoPolitics Pulse

The Heartbeat of World events

Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union

by ·

If marketing authorisation is granted by the European Commission (EC), Eydenzelt would be one of the first-wave aflibercept biosimilars in Europe.Read More

Related posts:

  1. Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
  2. Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union
  3. Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in …
  4. Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in …
  5. Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in …